Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs

By O'Hagan D.   Goldbeck C.   Ugozzoli M.   Ott G.   Burke R.L.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2229-2236

Elsevier

Access to resources Recommend Favorite

The effect of pre-existing adenovirus-specific immunity on immune responses induced by recombinant adenovirus expressing glycoprotein D of bovine herpesvirus type 1

By Papp Z.   Babiuk L.A.   Baca-Estrada M.E.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 933-943

Elsevier

Access to resources Recommend Favorite

Musosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

By Verweij W.R.   de Haan L.   Holtrop M.   Agsteribbe E.   Brands R.   van Scharrenburg G.J.M.   Wilschut J.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2069-2076

Elsevier

Access to resources Recommend Favorite

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant

By Wu H.-Y.   Russell M.W.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 286-292

Elsevier

Access to resources Recommend Favorite

A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D

By Cruz P.E.   Khalil P.L.   Dryden T.D.   Chiou H.C.   Fink P.S.   Berberich S.J.   Bigley N.J.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1091-1099

Elsevier

Access to resources Recommend Favorite